Medication overdoses and toxicities: Pathology review

00:00 / 00:00

Questions

USMLE® Step 1 style questions USMLE

of complete

A 57-year-old man comes to his primary care physician for evaluation of new onset blood in his urine. The patient first noticed the blood early this morning. He does not have dysuria or abdominal or suprapubic pain. He had a mitral valve replacement last year, and he is currently taking warfarin. Vital signs are within normal limits. The patient’s INR is 3.5. Further history is most likely to reveal administration of which of the following medications?

Transcript

Watch video only

A 19 year old young man named Cameron is brought to the emergency room by his father, who found Cameron vomiting next to a half-empty bottle of aspirin. Cameron tells you that he has a headache and is hearing a weird ringing noise. You decide to perform a blood test, which reveals that Cameron has metabolic acidosis.

Later that day, 32 year old Adaline presents in the emergency room due to nausea, vomiting, and slurred speech. Adaline reports that she has the flu and has been taking ibuprofen for the last couple of days. You notice that Adaline is very thirsty, and she also keeps going to the restroom to urinate. Her history reveals that she was diagnosed with bipolar disorder a few years ago, and is currently under treatment with lithium.

Based on their history and presentation, both Cameron and Adaline seem to have some type of medication overdose or toxicity. An overdose refers to taking too much of a substance, and can result in toxicity, which refers to how harmful that substance can be to the body.

Now, let’s go over some pharmacology basics. The therapeutic index, or TI for short, is a quantitative measurement of a drug’s dosing and its safety. For your exams, you should know that the TI is calculated as the ratio of the median toxic dose or TD50, which is the dose that causes a toxic response in 50% of the population, over the median effective dose or ED50, which is the dose that causes a therapeutic effect in 50% of the population.

Now, if the test question gives you a median lethal dose or LD50 for short instead of TD50, don’t panic! These two can be used interchangeably in the formula, but keep in mind that TD50 refers to human clinical trials, while LD50 refers to animal studies, and is defined as the dose that causes death in 50% of tested animals.

The important thing to note here is that medications with a wide therapeutic index are safer, since their toxic dose is much higher than their effective dose. On the flip side, medications with a narrow therapeutic index are more dangerous, since they have close toxic and effective doses.

Now, in contrast to the therapeutic index, there is the therapeutic window, which is defined as the range of blood concentrations at which a medication can give therapeutic effects while avoiding toxicity. The therapeutic window refers to any blood concentration of a given drug that’s between two parameters. The first one is minimum effective concentration or MEC, which refers to the minimum concentration that has therapeutic effects. The other one is minimum toxic concentration or MTC, which refers to the minimum concentration that has toxic effects. Everything between these two concentrations represents the therapeutic window.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition" McGraw Hill Professional (2012)
  4. "Anticholinesterases and anticholinergic drugs" Continuing Education in Anaesthesia Critical Care & Pain (2004)
  5. "Paracetamol and fever management" Journal of the Royal Society for the Promotion of Health (2008)
  6. "Chemical and Mechanical Alternatives to Leech Therapy: A Systematic Review and Critical Appraisal" Journal of Reconstructive Microsurgery (2011)
  7. "Clinical Laboratory Medicine" Lippincott Williams & Wilkins (2002)
Elsevier

Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Cookies are used by this site.

USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.

RELX